75 related articles for article (PubMed ID: 1656139)
1. Hematopathologic features of Epstein-Barr virus-induced human B-lymphoproliferation in mice with severe combined immunodeficiency. A model of lymphoproliferative diseases in immunocompromised patients.
Nakamine H; Okano M; Taguchi Y; Pirruccello SJ; Davis JR; Beisel KW; Kleveland K; Sanger WG; Fordyce RR; Purtilo DT
Lab Invest; 1991 Oct; 65(4):389-99. PubMed ID: 1656139
[TBL] [Abstract][Full Text] [Related]
2. Human immunoglobulin preparations suppress the occurrence of Epstein-Barr virus-associated lymphoproliferation.
Nadal D; Guzman J; Fröhlich S; Braun DG
Exp Hematol; 1997 Mar; 25(3):223-31. PubMed ID: 9091298
[TBL] [Abstract][Full Text] [Related]
3. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
[TBL] [Abstract][Full Text] [Related]
4. Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study.
Eisenbeis CF; Grainger A; Fischer B; Baiocchi RA; Carrodeguas L; Roychowdhury S; Chen L; Banks AL; Davis T; Young D; Kelbick N; Stephens J; Byrd JC; Grever MR; Caligiuri MA; Porcu P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6101-10. PubMed ID: 15447996
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic characterization of B-cell lymphomas from severe combined immunodeficiency disease mice given injections of lymphocytes from Epstein-Barr virus-positive donors.
Thangavelu M; Snyder L; Anastasi J; Le Beau MM; Kirven M; Picchio G; Mosier DE; Rowley JD
Cancer Res; 1992 Sep; 52(17):4678-81. PubMed ID: 1324790
[TBL] [Abstract][Full Text] [Related]
6. Evolution of clonality and invasive behavior of Epstein-Barr virus immortalized lymphoblastoid cell lines in SCID mice brains.
Bashir R; Masih A; Kallweit K; Fordyce-Boyer R; Sanger W; Purtilo D
Lab Invest; 1992 Oct; 67(4):450-6. PubMed ID: 1331608
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 6 in human immunodeficiency virus-infected individuals: association with early histologic phases of lymphadenopathy syndrome but not with malignant lymphoproliferative disorders.
Dolcetti R; Di Luca D; Carbone A; Mirandola P; De Vita S; Vaccher E; Sighinolfi L; Gloghini A; Tirelli U; Cassai E; Boiocchi M
J Med Virol; 1996 Apr; 48(4):344-53. PubMed ID: 8699167
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
[TBL] [Abstract][Full Text] [Related]
11. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma.
Marcus H; Burakova T; Shezen E; David M; Canaan A; Lubin I; Reisner Y
Immunol Lett; 1996 Mar; 49(3):155-61. PubMed ID: 8739310
[TBL] [Abstract][Full Text] [Related]
12. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
Woodford NL; Call DR; Remick DG; Rochford R
Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate reduces rituximab-induced tumor-growth inhibition in vivo on Epstein-Barr virus-associated human B-cell lymphoma.
Némati F; Mathiot C; Grandjean I; Lantz O; Bordier V; Dewulf S; Ekue R; Di Santo JP; Poupon MF; Decaudin D
Anticancer Drugs; 2007 Oct; 18(9):1029-37. PubMed ID: 17704653
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 8-associated solid lymphomas that occur in AIDS patients take anaplastic large cell morphology.
Katano H; Suda T; Morishita Y; Yamamoto K; Hoshino Y; Nakamura K; Tachikawa N; Sata T; Hamaguchi H; Iwamoto A; Mori S
Mod Pathol; 2000 Jan; 13(1):77-85. PubMed ID: 10658913
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
[TBL] [Abstract][Full Text] [Related]
17. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.
Khatri VP; Baiocchi RA; Bernstein ZP; Caligiuri MA
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S129-36. PubMed ID: 9457408
[TBL] [Abstract][Full Text] [Related]
19. EBV-associated lymphoproliferative disorders: classification and treatment.
Carbone A; Gloghini A; Dotti G
Oncologist; 2008 May; 13(5):577-85. PubMed ID: 18515742
[TBL] [Abstract][Full Text] [Related]
20. Post-transplantation lymphoproliferative disorders in Mexico: an aggressive clonal disease associated with Epstein-Barr virus type A.
Quintanilla-Martínez L; Lome-Maldonado C; Schwarzmann F; Gredler E; Reyes E; Angeles-Angeles A; Fend F
Mod Pathol; 1998 Feb; 11(2):200-8. PubMed ID: 9504692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
